Soni Medicare

  • Market Cap: N/A
  • Industry: Hospital
  • ISIN: INE848R01018
  • NSEID:
  • BSEID: 539378
INR
71.90
0.00 (0.00%)
BSENSE

Jun 17

BSE+NSE Vol: 50

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

71.9071.90

52 Week

0.000.00
Valuation
Technical
Day's Volume

CASH

50.0 (150.00%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

69.79%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

INR 31 Cr ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

60

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

-24.97

Revenue and Profits:
Net Sales:
6 Cr
(Quarterly Results - Mar 2026)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.39%
0%
2.39%
6 Months
-28.6%
0%
-28.6%
1 Year
40.98%
0%
40.98%
2 Years
149.91%
0%
149.91%
3 Years
292.68%
0%
292.68%
4 Years
212.61%
0%
212.61%
5 Years
0%
0%
0.0%

Soni Medicare for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Soni Medicare Ltd is Rated Strong Sell

Soni Medicare Ltd is Rated Strong Sell

Soni Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall market stance.

Read More
Soni Medicare Ltd is Rated Strong Sell

Soni Medicare Ltd is Rated Strong Sell

Soni Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read More
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

02-Jun-2026 | Source : BSE

Submission of Newspaper publication of audited Standalone Financial Results for the Quarter and year ended March 31st 2026.

Board Meeting Outcome for Meeting Held On 30Th May 2026 Pursuant To Regulation 30 Of SEBI(Listing Obligations And Disclosure Requirements) Regulations 2015

30-May-2026 | Source : BSE

Following Decisions were taken-1.Considered approved and took on record the audited Financial Results of the company for the quarter and the Financial Year ended March 2026 along with the report of the Auditors thereon.

Results- Financial Result For Mar 31 2026

30-May-2026 | Source : BSE

The Audited Financial Results of the company for the quarter and Financial Year ended 31st March 2026 along with the Audit Report of the Auditors thereon

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.36%
EBIT Growth (5y)
-189.05%
EBIT to Interest (avg)
-0.22
Debt to EBITDA (avg)
2.22
Net Debt to Equity (avg)
-8.92
Sales to Capital Employed (avg)
2.31
Tax Ratio
9.84%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-2.67%
ROE (avg)
1.73%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
60
Price to Book Value
-24.73
EV to EBIT
-29.18
EV to EBITDA
-41.72
EV to Capital Employed
4.25
EV to Sales
1.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.56%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Bimal Roy Soni (39.1%)

Highest Public shareholder

Vikram Phelpher (4.69%)

Individual Investors Holdings

26.18%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 8.77% vs -13.96% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 67.26% vs -22.83% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.83",
          "val2": "5.36",
          "chgp": "8.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.18",
          "val2": "-0.66",
          "chgp": "127.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "0.34",
          "chgp": "5.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.37",
          "val2": "-1.13",
          "chgp": "67.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.09%",
          "val2": "-12.31%",
          "chgp": "15.40%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Soni Medicare"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Soni Medicare"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -17.19% vs 9.46% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -1,326.32% vs 88.69% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24.71",
          "val2": "29.84",
          "chgp": "-17.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.91",
          "val2": "1.27",
          "chgp": "-171.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.22",
          "val2": "0.99",
          "chgp": "23.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-2.71",
          "val2": "-0.19",
          "chgp": "-1,326.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.68%",
          "val2": "4.26%",
          "chgp": "-7.94%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary
Mar'26
Dec'25
Change(%)
Net Sales
5.83
5.36
8.77%
Operating Profit (PBDIT) excl Other Income
0.18
-0.66
127.27%
Interest
0.36
0.34
5.88%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.37
-1.13
67.26%
Operating Profit Margin (Excl OI)
3.09%
-12.31%
15.40%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 8.77% vs -13.96% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 67.26% vs -22.83% in Dec 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
24.71
29.84
-17.19%
Operating Profit (PBDIT) excl Other Income
-0.91
1.27
-171.65%
Interest
1.22
0.99
23.23%
Exceptional Items
0.00
0.00
Standalone Net Profit
-2.71
-0.19
-1,326.32%
Operating Profit Margin (Excl OI)
-3.68%
4.26%
-7.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -17.19% vs 9.46% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is -1,326.32% vs 88.69% in Mar 2025

All Annual Resultsstock-summary
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."